kuda8
Posted - 09/25/24
$THRX end of game , got 0,0069€ per share !
NVDAMillionaire
Posted - 3 months ago
$THRX Theseus Pharmaceuticals, Inc. (NASDAQ:THRX): Navigating the Challenges of Targeted Oncology Development http://beyondspx.com/2024/08/05/theseus-pharmaceuticals-inc-nasdaqthrx-navigating-the-challenges-of-targeted-oncology-development/
Delta_Trader_
Posted - 9 months ago
$MCRB Tang also increased their holding of $THRX before the buyout… I will add to my position next week
https://www.fiercebiotech.com/biotech/concentra-scores-another-win-theseus-agrees-buyout-offer
slowasturtle
Posted - 9 months ago
$THRX waht happens if I don't take the offer?
Ninja_Tradez
Posted - 9 months ago
📢 $THRX -Theseus Pharmaceuticals Announces Closing of Tender Offer https://newsfilter.io/a/2787073690c97e6a21fc21dd86d4c7cd
Stock_Titan
Posted - 9 months ago
$THRX Theseus Pharmaceuticals Announces Closing of Tender Offer
https://www.stocktitan.net/news/THRX/theseus-pharmaceuticals-announces-closing-of-tender-x95ssvy6w1t6.html
Mergerbrief
Posted - 9 months ago
$THRX/Concentra Biosciences - Expected Completion Mergerbrief.com
tradethehalt
Posted - 9 months ago
$THRX trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $4.08 Vol: 3.12M.
cctranscripts
Posted - 10 months ago
Concentra MERGER SUB just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12862628 $THRX
cctranscripts
Posted - 10 months ago
Solicitation, recommendation statements https://www.conferencecalltranscripts.org/summary/?id=12856766 $THRX
cctranscripts
Posted - 10 months ago
Theravance just filed its Tender offer statement by Third Party http://www.sec.gov/Archives/edgar/data/1745020/000114036124001546/0001140361-24-001546-index.htm $THRX
EarningsInsider
Posted - 12/29/23
Theseus Pharmaceuticals Sees Short Interest Decrease from 1,620,000 shares to 936,000 shares. $THRX https://www.marketbeat.com/stocks/NASDA
StockAutomatePro
Posted - 12/29/23
$THRX The chart shows the stock may be headed for a boost. We alerted the BUY signal at $3.81 and we were able to close this one with profit at $4.18 🎯 See more details at StockAutomate.com
cctranscripts
Posted - 12/28/23
Concentra Biosciences, LLC just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12825548 $THRX
cctranscripts
Posted - 12/27/23
OrbiMed Genesis GP LLC just provided an update on activist position in Theravance https://www.conferencecalltranscripts.org/summary/?id=12824216 $THRX
JillBrown124
Posted - 12/26/23
$BTCT $ALLO $ATNM $THRX ✅ If you really want to make huge profits on trading then, highly recommended for you.,💖 top-stocks-winning-great-us.blogspot.com/2023/11/blog-post.html
tickeron
Posted - 12/24/23
A.I.dvisor made a bullish call on $THRX, netting in a 12.33% gain over 2 days https://srnk.us/go/4950258
ajobst
Posted - 12/23/23
$AUPH so the sale of $THRX was just announced, with a CVR associated with the potential sale of parts of their pipeline that the acquiring company did not want. Is it possible that something similar is going on with AUPH and AUR 200? Is AUR 200 easier to spin off with the IND application filed?
ajobst
Posted - 12/23/23
$THRX Any idea what the CVR could be worth? Market doesn't seem to think it's worth much. Debating whether to sell now, or hold through the merger to get the CVR. Tiny position for me...I'll probably just wait...a couple of months is no biggie for maybe another $0.10+/share.
ChartMill
Posted - 10 months ago
$THRX: Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra
https://www.chartmill.com/stock/quote/THRX/news?utm_source=prnews-2023-12-22-shareholder-alert-ademi-llp-investigates-whether-theseus-pharmaceuticals-inc-has-obtained-a-fair-price-in-its-transaction-with-concentra&utm_medium=stocktwits&utm_campaign=pressRelease
OpenOutcrier
Posted - 10 months ago
$THRX (+7.6% pre) Theseus Pharmaceuticals (THRX) Acquired by Concentra Biosciences for $3.90-$4.05/sh Cash Plus CVR - SI https://ooc.bz/l/20530
RonFarms
Posted - 10 months ago
$THRX watch inbs...
Market_Max
Posted - 10 months ago
$TECX Check out the $THRX story line. Very interesting. Just got bought out for cash plus CVR. Patiently waiting for AVRO.
ChartMill
Posted - 10 months ago
$THRX: Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
https://www.chartmill.com/stock/quote/THRX/news?utm_source=prnews-2023-12-22-theseus-pharmaceuticals-enters-into-agreement-to-be-acquired-by-concentra-biosciences-for-between-390-and-405-in-cash-per-share-plus-a-contingent-value-right&utm_medium=stocktwits&utm_campaign=pressRelease
cctranscripts
Posted - 10 months ago
Written communication relating to third party tender offer https://www.conferencecalltranscripts.org/summary/?id=12817231 $THRX
cctranscripts
Posted - 10 months ago
Theravance: Theseus Pharmaceuticals Enters Into Agreement To Be Acquired By Concentra Bioscienc https://www.conferencecalltranscripts.org/summary/?id=12817212 $THRX
Last10K
Posted - 10 months ago
$THRX just filed with the SEC a New Agreement, a Ending Agreement, a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/THRX/0001104659-23-128468.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=THRX
DonCorleone77
Posted - 10 months ago
$THRX 2 of 2 - Theseus Pharmaceuticals to be acquired by Concentra for $3.90-$4.05 per share ...the acquisition by Concentra - of which Tang Capital Partners is the controlling shareholder - is in the best interests of all Theseus shareholders, and has unanimously approved the merger agreement. Pursuant and subject to the terms of the merger agreement, a wholly owned subsidiary of Concentra will commence a tender offer by January 9 to acquire all outstanding shares of Theseus common stock. Closing of the offer is subject to certain conditions, including the tender of Theseus common stock representing at least a majority of the total number of outstanding shares; the availability of at least $187.6M of cash, net of transaction costs, wind-down costs and other liabilities, at closing, and other customary closing conditions. Theseus shareholders holding approximately 59% of Theseus common stock have signed support agreements under which such shareholders agreed to tender....
DonCorleone77
Posted - 10 months ago
$THRX 1 of 2 - Theseus Pharmaceuticals to be acquired by Concentra for $3.90-$4.05 per share Theseus Pharmaceuticals announced it has entered into a definitive merger agreement whereby Concentra Biosciences will acquire Theseus for a price per share of Theseus common stock of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an additional cash amount of not more than 15c per share at the closing of the merger, plus one non-tradeable contingent value right, or CVR, representing the right to receive 80% of the net proceeds from any license or disposition of Theseus' programs effected within 180 days of closing of the merger and 50% of the potential aggregate value of certain specified potential cost savings realized within 180 days of the close of the merger, pursuant to a CVR agreement. Following a thorough review process conducted with the assistance of its legal and financial advisors, Theseus' board of directors has determined that....